Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Gains from Investment Securities (2020 - 2026)

Journey Medical filings provide 6 years of Gains from Investment Securities readings, the most recent being $1.5 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 7088.3% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 452.95% increase, with the full-year FY2025 number at $1.5 million, down 38.93% from a year prior.
  • Gains from Investment Securities hit $1.5 million in Q4 2025 for Journey Medical, down from $1.5 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $3.1 million in Q2 2023 to a low of $1000.0 in Q4 2021.
  • Median Gains from Investment Securities over the past 5 years was $816750.0 (2022), compared with a mean of $1.1 million.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 14800.0% in 2022 and later crashed 98.96% in 2023.
  • Journey Medical's Gains from Investment Securities stood at $1000.0 in 2021, then skyrocketed by 14800.0% to $149000.0 in 2022, then tumbled by 35.57% to $96000.0 in 2023, then tumbled by 78.12% to $21000.0 in 2024, then skyrocketed by 7088.3% to $1.5 million in 2025.
  • The last three reported values for Gains from Investment Securities were $1.5 million (Q4 2025), $1.5 million (Q3 2025), and $2.8 million (Q2 2025) per Business Quant data.